Hirtle Callaghan & Co LLC
- SEC CIK
- 0001360710
- Latest filing
- Aug 14, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Hirtle Callaghan & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 390
- Value
- $243.2K
- % of portfolio
- <0.1%
- Quarters held
- 1
- Since Q2 2026